/
Stock
/
/
APIChangelogInfo

TRAVERE THERAPEUTICS

Trade TVTX
TVTX Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-05-15
2025-05-16
BAYNES ROY
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
WILLIAMS BRINKLEY RUTH
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
MECKLER JEFFREY
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
ORWIN JOHN
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
SQUARER RON
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
BAYNES ROY
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
BRUHN SUZANNE LOUISE
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
MECKLER JEFFREY
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
BAYNES ROY
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
LYONS GARY
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
BRUHN SUZANNE LOUISE
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
COUGHLIN TIMOTHY
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
COUGHLIN TIMOTHY
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
LYONS GARY
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
LYONS GARY
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
MECKLER JEFFREY
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
LYONS GARY
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
BAYNES ROY
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
MECKLER JEFFREY
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
ORWIN JOHN
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
ORWIN JOHN
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
POOLE SANDRA
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
POOLE SANDRA
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
SQUARER RON
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
SQUARER RON
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
WILLIAMS BRINKLEY RUTH
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
WILLIAMS BRINKLEY RUTH
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
BRUHN SUZANNE LOUISE
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
BRUHN SUZANNE LOUISE
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
COUGHLIN TIMOTHY
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
COUGHLIN TIMOTHY
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
ORWIN JOHN
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
POOLE SANDRA
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
POOLE SANDRA
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
SQUARER RON
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2025-05-15
2025-05-16
WILLIAMS BRINKLEY RUTH
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2025-05-05
2025-05-05
REED ELIZABETH
Chief Legal Officer and GC
S - Sale
Common Stock
-4,920
$21.00
-103K
1
$1.33B
2025-05-05
2025-05-05
ROTE WILLIAM
Chief Research Officer
S - Sale
Common Stock
-3,198
$21.00
-67,158
1
$1.33B
2025-05-05
2025-05-05
HEERMA PETER
CHIEF COMMERCIAL OFFICER
S - Sale
Common Stock
-1,771
$21.00
-37,191
1
$1.33B
2025-05-05
2025-05-05
DUBE ERIC
CHIEF EXECUTIVE OFFICER
S - Sale
Common Stock
-18,924
$21.00
-397K
1
$1.33B
2025-05-05
2025-05-05
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,784
$21.00
-37,464
1
$1.33B
2025-05-02
2025-05-05
HEERMA PETER
CHIEF COMMERCIAL OFFICER
M - Exercise
Common Stock
4,920
1
$1.33B
2025-05-02
2025-05-05
HEERMA PETER
CHIEF COMMERCIAL OFFICER
M - Exercise
Common Stock
4,920
1
$1.33B
2025-05-02
2025-05-05
REED ELIZABETH
Chief Legal Officer and GC
M - Exercise
Performance-based restricted stock units
-4,920
$0.00
1
$1.33B
2025-05-02
2025-05-05
REED ELIZABETH
Chief Legal Officer and GC
M - Exercise
Common Stock
4,920
1
$1.33B
2025-05-02
2025-05-05
ROTE WILLIAM
Chief Research Officer
M - Exercise
Performance-based restricted stock units
-4,920
$0.00
1
$1.33B
2025-05-02
2025-05-05
ROTE WILLIAM
Chief Research Officer
M - Exercise
Common Stock
4,920
1
$1.33B
2025-05-02
2025-05-05
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
M - Exercise
Performance-based restricted stock units
-4,920
$0.00
1
$1.33B
2025-05-02
2025-05-05
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
4,920
1
$1.33B
2025-05-02
2025-05-05
DUBE ERIC
CHIEF EXECUTIVE OFFICER
M - Exercise
Performance-based restricted stock units
-18,924
$0.00
1
$1.33B
2025-05-02
2025-05-05
DUBE ERIC
CHIEF EXECUTIVE OFFICER
M - Exercise
Common Stock
18,924
1
$1.33B
2025-05-02
2025-05-05
HEERMA PETER
CHIEF COMMERCIAL OFFICER
M - Exercise
Performance-based restricted stock units
-4,920
$0.00
1
$1.33B
2025-05-02
2025-05-05
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
M - Exercise
Performance-based restricted stock units
-4,920
$0.00
1
$1.33B
2025-05-02
2025-05-05
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
4,920
1
$1.33B
2025-05-02
2025-05-05
DUBE ERIC
CHIEF EXECUTIVE OFFICER
M - Exercise
Performance-based restricted stock units
-18,924
$0.00
1
$1.33B
2025-05-02
2025-05-05
DUBE ERIC
CHIEF EXECUTIVE OFFICER
M - Exercise
Common Stock
18,924
1
$1.33B
2025-05-02
2025-05-05
HEERMA PETER
CHIEF COMMERCIAL OFFICER
M - Exercise
Performance-based restricted stock units
-4,920
$0.00
1
$1.33B
2025-05-02
2025-05-05
REED ELIZABETH
Chief Legal Officer and GC
M - Exercise
Performance-based restricted stock units
-4,920
$0.00
1
$1.33B
2025-05-02
2025-05-05
REED ELIZABETH
Chief Legal Officer and GC
M - Exercise
Common Stock
4,920
1
$1.33B
2025-05-02
2025-05-05
ROTE WILLIAM
Chief Research Officer
M - Exercise
Performance-based restricted stock units
-4,920
$0.00
1
$1.33B
2025-05-02
2025-05-05
ROTE WILLIAM
Chief Research Officer
M - Exercise
Common Stock
4,920
1
$1.33B
2025-04-11
2025-04-14
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-48
$13.00
-624
1
$1.33B
2025-02-12
2025-02-12
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
S - Sale
Common Stock
-5,200
$24.00
-125K
1
$1.33B
2025-02-12
2025-02-12
HEERMA PETER
CHIEF COMMERCIAL OFFICER
S - Sale
Common Stock
-2,568
$24.00
-61,632
1
$1.33B
2025-02-12
2025-02-12
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
S - Sale
Common Stock
-8,000
$24.00
-192K
1
$1.33B
2025-02-12
2025-02-12
INRIG JULA
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-2,568
$24.00
-61,632
1
$1.33B
2025-02-11
2025-02-12
DUBE ERIC
CHIEF EXECUTIVE OFFICER
S - Sale
Common Stock
-11,375
$24.00
-273K
1
$1.33B
2025-02-11
2025-02-12
HEERMA PETER
CHIEF COMMERCIAL OFFICER
S - Sale
Common Stock
-3,074
$25.00
-76,850
1
$1.33B
2025-02-11
2025-02-12
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
M - Exercise
Common Stock
45,000
$17.00
765K
4
$1.33B
2025-02-11
2025-02-12
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
M - Exercise
Employee stock option (right to buy)
-45,000
$0.00
4
$1.33B
2025-02-11
2025-02-12
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
S - Sale
Common Stock
-54,244
$25.00
-1.36M
5
$1.33B
2025-02-10
2025-02-12
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
M - Exercise
Performance-based restricted stock units
-8,000
$0.00
1
$1.33B
2025-02-10
2025-02-12
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
M - Exercise
Common Stock
8,000
1
$1.33B
2025-02-10
2025-02-12
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
M - Exercise
Performance-based restricted stock units
-8,000
$0.00
1
$1.33B
2025-02-10
2025-02-12
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
M - Exercise
Common Stock
8,000
1
$1.33B
2025-02-10
2025-02-12
HEERMA PETER
CHIEF COMMERCIAL OFFICER
M - Exercise
Performance-based restricted stock units
-8,000
$0.00
1
$1.33B
2025-02-10
2025-02-12
HEERMA PETER
CHIEF COMMERCIAL OFFICER
M - Exercise
Common Stock
8,000
1
$1.33B
2025-02-10
2025-02-12
INRIG JULA
CHIEF MEDICAL OFFICER
M - Exercise
Performance-based restricted stock units
-8,000
$0.00
1
$1.33B
2025-02-10
2025-02-12
INRIG JULA
CHIEF MEDICAL OFFICER
M - Exercise
Common Stock
8,000
1
$1.33B
2025-02-06
2025-02-10
BAYNES ROY
M - Exercise
Stock option (right to buy)
-10,000
$0.00
1
$1.33B
2025-02-06
2025-02-10
BAYNES ROY
M - Exercise
Common Stock
10,000
$17.00
170K
1
$1.33B
2025-02-06
2025-02-10
BAYNES ROY
S - Sale
Common Stock
-10,000
$22.00
-220K
1
$1.33B
2025-02-04
2025-02-04
INRIG JULA
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-1,066
$20.00
-21,320
1
$1.33B
2025-02-03
2025-02-04
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
S - Sale
Common Stock
-3,348
$20.00
-66,960
1
$1.33B
2025-02-03
2025-02-04
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
S - Sale
Common Stock
-8,951
$20.00
-179K
1
$1.33B
2025-02-03
2025-02-04
DUBE ERIC
CHIEF EXECUTIVE OFFICER
S - Sale
Common Stock
-50,691
$20.00
-1.01M
1
$1.33B
2025-02-03
2025-02-04
INRIG JULA
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-4,207
$20.00
-84,140
1
$1.33B
2025-02-03
2025-02-04
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
S - Sale
Common Stock
-8,951
$20.00
-179K
1
$1.33B
2025-02-03
2025-02-04
HEERMA PETER
CHIEF COMMERCIAL OFFICER
S - Sale
Common Stock
-5,166
$20.00
-103K
1
$1.33B
2025-02-03
2025-02-04
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-5,192
$20.00
-104K
1
$1.33B
2025-01-31
2025-02-04
HEERMA PETER
CHIEF COMMERCIAL OFFICER
A - Grant
Common Stock
21,500
$0.00
1
$1.33B
2025-01-31
2025-02-04
DUBE ERIC
CHIEF EXECUTIVE OFFICER
A - Grant
Common Stock
130K
$0.00
1
$1.33B
2025-01-31
2025-02-04
HEERMA PETER
CHIEF COMMERCIAL OFFICER
A - Grant
Employee stock option (right to buy)
58,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
INRIG JULA
CHIEF MEDICAL OFFICER
A - Grant
Common Stock
30,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
A - Grant
Common Stock
21,500
$0.00
1
$1.33B
2025-01-31
2025-02-04
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
A - Grant
Employee stock option (right to buy)
26,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
A - Grant
Common Stock
13,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
A - Grant
Employee stock option (right to buy)
58,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
21,500
$0.00
1
$1.33B
2025-01-31
2025-02-04
DUBE ERIC
CHIEF EXECUTIVE OFFICER
A - Grant
Employee stock option (right to buy)
260K
$0.00
1
$1.33B
2025-01-31
2025-02-04
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
A - Grant
Employee stock option (right to buy)
26,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
A - Grant
Common Stock
13,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
A - Grant
Employee stock option (right to buy)
58,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
21,500
$0.00
1
$1.33B
2025-01-31
2025-02-04
DUBE ERIC
CHIEF EXECUTIVE OFFICER
A - Grant
Employee stock option (right to buy)
260K
$0.00
1
$1.33B
2025-01-31
2025-02-04
DUBE ERIC
CHIEF EXECUTIVE OFFICER
A - Grant
Common Stock
130K
$0.00
1
$1.33B
2025-01-31
2025-02-04
HEERMA PETER
CHIEF COMMERCIAL OFFICER
A - Grant
Employee stock option (right to buy)
58,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
INRIG JULA
CHIEF MEDICAL OFFICER
A - Grant
Employee stock option (right to buy)
100K
$0.00
1
$1.33B
2025-01-31
2025-02-04
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
A - Grant
Employee stock option (right to buy)
58,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
A - Grant
Common Stock
21,500
$0.00
1
$1.33B
2025-01-31
2025-02-04
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
A - Grant
Employee stock option (right to buy)
58,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
HEERMA PETER
CHIEF COMMERCIAL OFFICER
A - Grant
Common Stock
21,500
$0.00
1
$1.33B
2025-01-31
2025-02-04
INRIG JULA
CHIEF MEDICAL OFFICER
A - Grant
Employee stock option (right to buy)
100K
$0.00
1
$1.33B
2025-01-31
2025-02-04
INRIG JULA
CHIEF MEDICAL OFFICER
A - Grant
Common Stock
30,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
A - Grant
Employee stock option (right to buy)
58,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
A - Grant
Common Stock
21,500
$0.00
1
$1.33B
2025-01-31
2025-02-04
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
A - Grant
Employee stock option (right to buy)
58,000
$0.00
1
$1.33B
2025-01-31
2025-02-04
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
A - Grant
Common Stock
21,500
$0.00
1
$1.33B
2025-01-23
2025-01-23
BAYNES ROY
M - Exercise
Stock option (right to buy)
-16,000
$0.00
1
$1.33B
2025-01-23
2025-01-23
BAYNES ROY
S - Sale
Common Stock
-16,000
$20.00
-320K
1
$1.33B
2025-01-23
2025-01-23
BAYNES ROY
M - Exercise
Stock option (right to buy)
-16,000
$0.00
1
$1.33B
2025-01-23
2025-01-23
BAYNES ROY
M - Exercise
Common Stock
16,000
$18.00
288K
1
$1.33B
2025-01-23
2025-01-23
BAYNES ROY
M - Exercise
Common Stock
16,000
$18.00
288K
1
$1.33B
2025-01-23
2025-01-23
BAYNES ROY
S - Sale
Common Stock
-16,000
$20.00
-320K
1
$1.33B
2025-01-23
2025-01-23
BAYNES ROY
S - Sale
Common Stock
-16,000
$20.00
-320K
1
$1.33B
2025-01-23
2025-01-23
BAYNES ROY
M - Exercise
Stock option (right to buy)
-16,000
$0.00
1
$1.33B
2025-01-23
2025-01-23
BAYNES ROY
M - Exercise
Common Stock
16,000
$18.00
288K
1
$1.33B
2025-01-22
2025-01-23
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
S - Sale
Common Stock
-925
$19.00
-17,575
1
$1.33B
2025-01-22
2025-01-23
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-865
$19.00
-16,435
1
$1.33B
2025-01-22
2025-01-23
DUBE ERIC
CHIEF EXECUTIVE OFFICER
S - Sale
Common Stock
-10,736
$19.00
-204K
1
$1.33B
2025-01-22
2025-01-23
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
S - Sale
Common Stock
-2,437
$19.00
-46,303
1
$1.33B
2025-01-22
2025-01-23
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
S - Sale
Common Stock
-2,437
$19.00
-46,303
1
$1.33B
2025-01-22
2025-01-23
HEERMA PETER
CHIEF COMMERCIAL OFFICER
S - Sale
Common Stock
-1,584
$19.00
-30,096
1
$1.33B
2025-01-06
2025-01-06
INRIG JULA
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-440
$19.00
-8,360
1
$1.33B
2025-01-03
2025-01-06
INRIG JULA
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-2,066
$19.00
-39,254
1
$1.33B
2024-12-26
2024-12-27
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
M - Exercise
Employee stock option (right to buy)
-15,000
$0.00
1
$1.33B
2024-12-26
2024-12-27
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
M - Exercise
Common Stock
15,000
$13.00
195K
1
$1.33B
2024-12-26
2024-12-27
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
S - Sale
Common Stock
-15,000
$17.00
-255K
1
$1.33B
2024-11-25
2024-11-25
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
S - Sale
Common Stock
-12,090
$18.00
-218K
1
$1.33B
2024-11-25
2024-11-25
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
M - Exercise
Employee stock option (right to buy)
-15,000
$0.00
1
$1.33B
2024-11-25
2024-11-25
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
M - Exercise
Common Stock
15,000
$13.00
195K
1
$1.33B
2024-10-04
2024-10-04
LYONS GARY
M - Exercise
Stock option (right to buy)
40,000
$0.00
1
$1.33B
2024-10-04
2024-10-04
LYONS GARY
M - Exercise
Common Stock
40,000
$10.00
400K
1
$1.33B
2024-10-04
2024-10-04
LYONS GARY
S - Sale
Common Stock
-40,000
$15.00
-600K
2
$1.33B
2024-09-30
2024-09-30
MECKLER JEFFREY
S - Sale
Common Stock
-40,000
$14.00
-560K
1
$1.33B
2024-09-30
2024-09-30
MECKLER JEFFREY
M - Exercise
Stock option (right to buy)
40,000
$0.00
1
$1.33B
2024-09-30
2024-09-30
MECKLER JEFFREY
M - Exercise
Common Stock
40,000
$10.00
400K
1
$1.33B
2024-09-11
2024-09-11
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
S - Sale
-15,000
$15.00
-225K
1
$1.33B
2024-09-10
2024-09-10
INRIG JULA
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-684
$13.00
-8,892
1
$1.33B
2024-09-09
2024-09-09
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
S - Sale
Common Stock
-4,387
$12.00
-52,644
1
$1.33B
2024-09-09
2024-09-09
DUBE ERIC
CHIEF EXECUTIVE OFFICER
S - Sale
Common Stock
-21,125
$12.00
-254K
1
$1.33B
2024-09-09
2024-09-09
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
S - Sale
Common Stock
-4,387
$12.00
-52,644
1
$1.33B
2024-09-09
2024-09-09
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-2,490
$12.00
-29,880
1
$1.33B
2024-09-09
2024-09-09
HEERMA PETER
CHIEF COMMERCIAL OFFICER
S - Sale
Common Stock
-2,191
$12.00
-26,292
1
$1.33B
2024-09-09
2024-09-09
INRIG JULA
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-2,191
$12.00
-26,292
1
$1.33B
2024-09-05
2024-09-09
HEERMA PETER
CHIEF COMMERCIAL OFFICER
A - Grant
Common Stock
6,750
$0.00
1
$1.33B
2024-09-05
2024-09-09
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
A - Grant
Common Stock
6,750
$0.00
1
$1.33B
2024-09-05
2024-09-09
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
A - Grant
Common Stock
6,750
$0.00
1
$1.33B
2024-09-05
2024-09-09
INRIG JULA
CHIEF MEDICAL OFFICER
A - Grant
Common Stock
6,750
$0.00
1
$1.33B
2024-09-05
2024-09-09
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
6,750
$0.00
1
$1.33B
2024-09-05
2024-09-09
DUBE ERIC
CHIEF EXECUTIVE OFFICER
A - Grant
Common Stock
32,500
$0.00
1
$1.33B
2024-09-04
2024-09-05
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-514
$10.00
-5,140
1
$1.33B
2024-05-08
2024-05-10
MECKLER JEFFREY
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
COUGHLIN TIMOTHY
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
BAYNES ROY
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
BAYNES ROY
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
BRUHN SUZANNE LOUISE
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
BRUHN SUZANNE LOUISE
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
COUGHLIN TIMOTHY
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
LYONS GARY
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
LYONS GARY
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
MECKLER JEFFREY
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
ORWIN JOHN
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
ORWIN JOHN
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
POOLE SANDRA
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
POOLE SANDRA
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
SQUARER RON
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
SQUARER RON
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
WILLIAMS BRINKLEY RUTH
A - Grant
Stock option (right to buy)
19,500
$0.00
1
$1.33B
2024-05-08
2024-05-10
WILLIAMS BRINKLEY RUTH
A - Grant
Common Stock
6,500
$0.00
1
$1.33B
2024-04-11
2024-04-12
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-54
$7.00
-378
1
$1.33B
2024-02-01
2024-02-02
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
S - Sale
Common Stock
-4,764
$9.00
-42,876
2
$1.33B
2024-02-01
2024-02-02
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
S - Sale
Common Stock
-2,820
$9.00
-25,380
1
$1.33B
2024-02-01
2024-02-02
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-3,818
$9.00
-34,362
1
$1.33B
2024-02-01
2024-02-02
DUBE ERIC
CHIEF EXECUTIVE OFFICER
S - Sale
Common Stock
-19,122
$9.00
-172K
2
$1.33B
2024-02-01
2024-02-02
HEERMA PETER
CHIEF COMMERCIAL OFFICER
S - Sale
Common Stock
-4,195
$9.00
-37,755
1
$1.33B
2024-02-01
2024-02-02
INRIG JULA
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-2,174
$9.00
-19,566
1
$1.33B
2024-02-01
2024-02-02
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
S - Sale
Common Stock
-4,764
$9.00
-42,876
2
$1.33B
2024-01-31
2024-02-02
HEERMA PETER
CHIEF COMMERCIAL OFFICER
A - Grant
Employee stock option (right to buy)
65,000
$0.00
1
$1.33B
2024-01-31
2024-02-02
HEERMA PETER
CHIEF COMMERCIAL OFFICER
A - Grant
Common Stock
25,000
$0.00
1
$1.33B
2024-01-31
2024-02-02
INRIG JULA
CHIEF MEDICAL OFFICER
A - Grant
Employee stock option (right to buy)
91,000
$0.00
1
$1.33B
2024-01-31
2024-02-02
INRIG JULA
CHIEF MEDICAL OFFICER
A - Grant
Common Stock
25,000
$0.00
1
$1.33B
2024-01-31
2024-02-02
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
A - Grant
Employee stock option (right to buy)
65,000
$0.00
1
$1.33B
2024-01-31
2024-02-02
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
A - Grant
Common Stock
25,000
$0.00
1
$1.33B
2024-01-31
2024-02-02
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
A - Grant
Employee stock option (right to buy)
65,000
$0.00
1
$1.33B
2024-01-31
2024-02-02
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
A - Grant
Common Stock
25,000
$0.00
1
$1.33B
2024-01-31
2024-02-02
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
A - Grant
Common Stock
13,500
$0.00
2
$1.33B
2024-01-31
2024-02-02
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
A - Grant
Employee stock option (right to buy)
65,000
$0.00
1
$1.33B
2024-01-31
2024-02-02
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
25,000
$0.00
1
$1.33B
2024-01-31
2024-02-02
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
A - Grant
Employee stock option (right to buy)
25,000
$0.00
1
$1.33B
2024-01-31
2024-02-02
DUBE ERIC
CHIEF EXECUTIVE OFFICER
A - Grant
Employee stock option (right to buy)
360K
$0.00
1
$1.33B
2024-01-31
2024-02-02
DUBE ERIC
CHIEF EXECUTIVE OFFICER
A - Grant
Common Stock
135K
$0.00
1
$1.33B
2024-02-01
2024-02-01
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
S - Sale
-2,174
$9.00
-19,566
1
$1.33B
2024-02-01
2024-02-01
DUBE ERIC
CHIEF EXECUTIVE OFFICER
S - Sale
-10,016
$9.00
-90,144
1
$1.33B
2024-02-01
2024-02-01
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
S - Sale
-2,174
$9.00
-19,566
1
$1.33B
2024-02-01
2024-02-01
DUBE ERIC
CHIEF EXECUTIVE OFFICER
S - Sale
-9,106
$9.00
-81,954
1
$1.33B
2024-02-01
2024-02-01
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
S - Sale
-2,590
$9.00
-23,310
1
$1.33B
2024-02-01
2024-02-01
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
S - Sale
-2,590
$9.00
-23,310
1
$1.33B
2024-01-23
2024-01-25
CALVIN SANDRA
SVP, CHIEF ACCOUNTING OFFICER
S - Sale
Common Stock
-910
$9.00
-8,190
1
$1.33B
2024-01-23
2024-01-25
CLINE CHRISTOPHER
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-853
$9.00
-7,677
1
$1.33B
2024-01-23
2024-01-25
DUBE ERIC
CHIEF EXECUTIVE OFFICER
S - Sale
Common Stock
-7,873
$9.00
-70,857
1
$1.33B
2024-01-23
2024-01-25
HEERMA PETER
CHIEF COMMERCIAL OFFICER
S - Sale
Common Stock
-1,559
$9.00
-14,031
1
$1.33B
2024-01-23
2024-01-25
REED ELIZABETH
SVP, GC & CORPORATE SECRETARY
S - Sale
Common Stock
-2,062
$9.00
-18,558
1
$1.33B
2024-01-23
2024-01-25
ROTE WILLIAM
SENIOR VICE PRESIDENT, R&D
S - Sale
Common Stock
-2,062
$9.00
-18,558
1
$1.33B
2024-01-04
2024-01-05
INRIG JULA
Chief Medical Officer
S - Sale
Common Stock
-440
$9.00
-3,960
1
$1.33B
2024-01-03
2024-01-05
INRIG JULA
Chief Medical Officer
S - Sale
Common Stock
-2,069
$9.00
-18,621
1
$1.33B
2023-10-03
2023-10-04
HEERMA PETER
Chief Commercial Officer
S - Sale
Common Stock
-3,091
$8.00
-24,728
1
$1.33B
2023-09-05
2023-09-05
CLINE CHRISTOPHER
Chief Financial Officer
S - Sale
Common Stock
-457
$15.00
-6,855
1
$1.33B
2023-09-05
2023-09-05
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-4,455
$15.00
-66,825
1
$1.33B
2023-09-05
2023-09-05
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-1,815
$15.00
-27,225
1
$1.33B
2023-09-05
2023-09-05
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-1,815
$15.00
-27,225
1
$1.33B
2023-08-31
2023-09-05
REED ELIZABETH
SVP, GC & Corporate Secretary
A - Grant
Common Stock
3,300
$0.00
1
$1.33B
2023-08-31
2023-09-05
ROTE WILLIAM
Senior Vice President, R&D
A - Grant
Common Stock
3,300
$0.00
1
$1.33B
2023-08-31
2023-09-05
DUBE ERIC
Chief Executive Officer
A - Grant
Common Stock
9,900
$0.00
1
$1.33B
2023-05-17
2023-05-19
WILLIAMS BRINKLEY RUTH
A - Grant
Stock option (right to buy)
13,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
BAYNES ROY
A - Grant
Stock option (right to buy)
13,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
BAYNES ROY
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
BRUHN SUZANNE LOUISE
A - Grant
Stock option (right to buy)
13,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
BRUHN SUZANNE LOUISE
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
COUGHLIN TIMOTHY
A - Grant
Stock option (right to buy)
13,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
COUGHLIN TIMOTHY
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
LYONS GARY
A - Grant
Stock option (right to buy)
13,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
LYONS GARY
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
MECKLER JEFFREY
A - Grant
Stock option (right to buy)
13,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
MECKLER JEFFREY
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
ORWIN JOHN
A - Grant
Stock option (right to buy)
13,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
ORWIN JOHN
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
POOLE SANDRA
A - Grant
Stock option (right to buy)
13,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
POOLE SANDRA
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
SQUARER RON
A - Grant
Stock option (right to buy)
13,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
SQUARER RON
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2023-05-17
2023-05-19
WILLIAMS BRINKLEY RUTH
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2023-05-11
2023-05-12
CALVIN SANDRA
SVP, Chief Accounting Officer
S - Sale
Common Stock
-122
$16.00
-1,952
1
$1.33B
2023-05-10
2023-05-12
CALVIN SANDRA
SVP, Chief Accounting Officer
S - Sale
Common Stock
-436
$17.00
-7,412
1
$1.33B
2023-05-10
2023-05-12
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-825
$17.00
-14,025
1
$1.33B
2023-05-10
2023-05-12
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-825
$17.00
-14,025
1
$1.33B
2023-05-10
2023-05-12
CLINE CHRISTOPHER
Chief Financial Officer
S - Sale
Common Stock
-455
$17.00
-7,735
1
$1.33B
2023-04-11
2023-04-13
CLINE CHRISTOPHER
Chief Financial Officer
S - Sale
Common Stock
-47
$21.00
-987
1
$1.33B
2023-02-02
2023-02-02
CALVIN SANDRA
SVP, Chief Accounting Officer
S - Sale
Common Stock
-360
$22.00
-7,920
1
$1.33B
2023-02-01
2023-02-02
CALVIN SANDRA
SVP, Chief Accounting Officer
S - Sale
Common Stock
-1,671
$22.00
-36,762
1
$1.33B
2023-02-01
2023-02-02
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-8,196
$22.00
-180K
1
$1.33B
2023-02-01
2023-02-02
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-2,590
$22.00
-56,980
1
$1.33B
2023-02-01
2023-02-02
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-2,590
$22.00
-56,980
1
$1.33B
2023-02-01
2023-02-02
CLINE CHRISTOPHER
Chief Financial Officer
S - Sale
Common Stock
-1,588
$22.00
-34,936
1
$1.33B
2023-02-01
2023-02-02
HEERMA PETER
Chief Commercial Officer
S - Sale
Common Stock
-1,779
$22.00
-39,138
1
$1.33B
2023-01-31
2023-02-02
INRIG JULA
Chief Medical Officer
A - Grant
Performance-based restricted stock units
6,750
$0.00
1
$1.33B
2023-01-31
2023-02-02
INRIG JULA
Chief Medical Officer
A - Grant
Common Stock
20,250
$0.00
1
$1.33B
2023-01-31
2023-02-02
REED ELIZABETH
SVP, GC & Corporate Secretary
A - Grant
Employee stock option (right to buy)
54,500
$0.00
1
$1.33B
2023-01-31
2023-02-02
REED ELIZABETH
SVP, GC & Corporate Secretary
A - Grant
Performance-based restricted stock units
6,750
$0.00
1
$1.33B
2023-01-31
2023-02-02
REED ELIZABETH
SVP, GC & Corporate Secretary
A - Grant
Common Stock
20,250
$0.00
1
$1.33B
2023-01-31
2023-02-02
ROTE WILLIAM
Senior Vice President, R&D
A - Grant
Performance-based restricted stock units
6,750
$0.00
1
$1.33B
2023-01-31
2023-02-02
ROTE WILLIAM
Senior Vice President, R&D
A - Grant
Common Stock
20,250
$0.00
1
$1.33B
2023-01-31
2023-02-02
ROTE WILLIAM
Senior Vice President, R&D
A - Grant
Employee stock option (right to buy)
54,500
$0.00
1
$1.33B
2023-01-31
2023-02-02
CALVIN SANDRA
SVP, Chief Accounting Officer
A - Grant
Employee stock option (right to buy)
20,000
$0.00
1
$1.33B
2023-01-31
2023-02-02
CALVIN SANDRA
SVP, Chief Accounting Officer
A - Grant
Common Stock
10,000
$0.00
1
$1.33B
2023-01-31
2023-02-02
CLINE CHRISTOPHER
Chief Financial Officer
A - Grant
Employee stock option (right to buy)
54,500
$0.00
1
$1.33B
2023-01-31
2023-02-02
CLINE CHRISTOPHER
Chief Financial Officer
A - Grant
Performance-based restricted stock units
6,750
$0.00
1
$1.33B
2023-01-31
2023-02-02
CLINE CHRISTOPHER
Chief Financial Officer
A - Grant
Common Stock
20,250
$0.00
1
$1.33B
2023-01-31
2023-02-02
DUBE ERIC
Chief Executive Officer
A - Grant
Employee stock option (right to buy)
260K
$0.00
1
$1.33B
2023-01-31
2023-02-02
DUBE ERIC
Chief Executive Officer
A - Grant
Performance-based restricted stock units
32,500
$0.00
1
$1.33B
2023-01-31
2023-02-02
DUBE ERIC
Chief Executive Officer
A - Grant
Common Stock
97,500
$0.00
1
$1.33B
2023-01-31
2023-02-02
HEERMA PETER
Chief Commercial Officer
A - Grant
Employee stock option (right to buy)
54,500
$0.00
1
$1.33B
2023-01-31
2023-02-02
HEERMA PETER
Chief Commercial Officer
A - Grant
Performance-based restricted stock units
6,750
$0.00
1
$1.33B
2023-01-31
2023-02-02
HEERMA PETER
Chief Commercial Officer
A - Grant
Common Stock
20,250
$0.00
1
$1.33B
2023-01-31
2023-02-02
INRIG JULA
Chief Medical Officer
A - Grant
Employee stock option (right to buy)
54,500
$0.00
1
$1.33B
2023-01-25
2023-01-26
CALVIN SANDRA
SVP, Chief Accounting Officer
S - Sale
Common Stock
-192
$22.00
-4,224
1
$1.33B
2023-01-24
2023-01-26
CLINE CHRISTOPHER
Chief Financial Officer
S - Sale
Common Stock
-852
$22.00
-18,744
1
$1.33B
2023-01-24
2023-01-26
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-6,442
$22.00
-142K
1
$1.33B
2023-01-24
2023-01-26
CALVIN SANDRA
SVP, Chief Accounting Officer
S - Sale
Common Stock
-905
$22.00
-19,910
1
$1.33B
2023-01-24
2023-01-26
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-2,062
$22.00
-45,364
1
$1.33B
2023-01-24
2023-01-26
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-2,062
$22.00
-45,364
1
$1.33B
2023-01-24
2023-01-26
HEERMA PETER
Chief Commercial Officer
S - Sale
Common Stock
-1,550
$22.00
-34,100
1
$1.33B
2023-01-05
2023-01-06
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-5,625
$21.00
-118K
1
$1.33B
2023-01-05
2023-01-06
INRIG JULA
Chief Medical Officer
S - Sale
Common Stock
-442
$21.00
-9,282
1
$1.33B
2023-01-04
2023-01-06
INRIG JULA
Chief Medical Officer
S - Sale
Common Stock
-2,051
$21.00
-43,071
1
$1.33B
2022-10-04
2022-10-06
HEERMA PETER
Chief Commercial Officer
S - Sale
Common Stock
-3,042
$26.00
-79,092
1
$1.33B
2022-09-13
2022-09-15
CALVIN SANDRA
SVP, Chief Accounting Officer
S - Sale
Common Stock
-349
$28.00
-9,772
1
$1.33B
2022-09-01
2022-09-01
CLINE CHRISTOPHER
Chief Financial Officer
A - Grant
Performance-based restricted stock units
9,840
$0.00
1
$1.33B
2022-09-01
2022-09-01
CLINE CHRISTOPHER
Chief Financial Officer
A - Grant
Common Stock
5,000
$0.00
1
$1.33B
2022-09-01
2022-09-01
CLINE CHRISTOPHER
Chief Financial Officer
A - Grant
Employee Stock option (right to buy)
48,000
$0.00
1
$1.33B
2022-05-12
2022-05-12
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-1,050
$22.00
-23,100
1
$1.33B
2022-05-11
2022-05-12
CLAGUE LAURA
Chief Financial Officer
S - Sale
Common Stock
-1,375
$22.00
-30,250
1
$1.33B
2022-05-11
2022-05-12
MECKLER JEFFREY
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
MECKLER JEFFREY
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
ORWIN JOHN
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
ORWIN JOHN
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
POOLE SANDRA
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
POOLE SANDRA
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
SQUARER RON
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
ASELAGE STEVE
S - Sale
Common Stock
-2,575
$22.00
-56,650
1
$1.33B
2022-05-11
2022-05-12
CALVIN SANDRA
SVP, Chief Accounting Officer
S - Sale
Common Stock
-445
$22.00
-9,790
1
$1.33B
2022-05-11
2022-05-12
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-1,563
$22.00
-34,386
2
$1.33B
2022-05-11
2022-05-12
BAYNES ROY
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
BAYNES ROY
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
BRUHN SUZANNE LOUISE
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
BRUHN SUZANNE LOUISE
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
COUGHLIN TIMOTHY
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
COUGHLIN TIMOTHY
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
LYONS GARY
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
LYONS GARY
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
SQUARER RON
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
WILLIAMS BRINKLEY RUTH
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2022-05-11
2022-05-12
WILLIAMS BRINKLEY RUTH
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2022-05-10
2022-05-12
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-900
$22.00
-19,800
1
$1.33B
2022-05-10
2022-05-12
CALVIN SANDRA
SVP, Chief Accounting Officer
S - Sale
Common Stock
-436
$22.00
-9,592
1
$1.33B
2022-05-10
2022-05-12
CLAGUE LAURA
Chief Financial Officer
S - Sale
Common Stock
-825
$22.00
-18,150
1
$1.33B
2022-02-10
2022-02-11
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-4,832
$28.00
-135K
1
$1.33B
2022-01-31
2022-02-02
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-4,813
$27.00
-130K
1
$1.33B
2022-01-31
2022-02-02
HEERMA PETER
Chief Commercial Officer
S - Sale
Common Stock
-1,125
$27.00
-30,375
1
$1.33B
2022-01-31
2022-02-02
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-1,350
$27.00
-36,450
1
$1.33B
2022-01-31
2022-02-02
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-1,125
$27.00
-30,375
1
$1.33B
2022-01-31
2022-02-02
CALVIN SANDRA
VP, Corp Controller and CAO
A - Grant
Employee stock option (right to buy)
17,500
$0.00
1
$1.33B
2022-01-31
2022-02-02
CLAGUE LAURA
Chief Financial Officer
A - Grant
Employee stock option (right to buy)
39,360
$0.00
1
$1.33B
2022-01-31
2022-02-02
CLAGUE LAURA
Chief Financial Officer
A - Grant
Performance-based restricted stock units
17,840
$0.00
2
$1.33B
2022-01-31
2022-02-02
CLAGUE LAURA
Chief Financial Officer
A - Grant
Common Stock
9,840
$0.00
1
$1.33B
2022-01-31
2022-02-02
DUBE ERIC
Chief Executive Officer
A - Grant
Employee stock option (right to buy)
170K
$0.00
1
$1.33B
2022-01-31
2022-02-02
DUBE ERIC
Chief Executive Officer
A - Grant
Performance-based restricted stock units
37,848
$0.00
1
$1.33B
2022-01-31
2022-02-02
DUBE ERIC
Chief Executive Officer
A - Grant
Common Stock
37,848
$0.00
1
$1.33B
2022-01-31
2022-02-02
HEERMA PETER
Chief Commercial Officer
A - Grant
Employee stock option (right to buy)
39,360
$0.00
1
$1.33B
2022-01-31
2022-02-02
HEERMA PETER
Chief Commercial Officer
A - Grant
Performance-based restricted stock units
17,840
$0.00
2
$1.33B
2022-01-31
2022-02-02
HEERMA PETER
Chief Commercial Officer
A - Grant
Common Stock
9,840
$0.00
1
$1.33B
2022-01-31
2022-02-02
INRIG JULA
Chief Medical Officer
A - Grant
Performance-based restricted stock units
8,000
$0.00
1
$1.33B
2022-01-31
2022-02-02
REED ELIZABETH
SVP, GC & Corporate Secretary
A - Grant
Employee stock option (right to buy)
39,360
$0.00
1
$1.33B
2022-01-31
2022-02-02
REED ELIZABETH
SVP, GC & Corporate Secretary
A - Grant
Performance-based restricted stock units
17,840
$0.00
2
$1.33B
2022-01-31
2022-02-02
REED ELIZABETH
SVP, GC & Corporate Secretary
A - Grant
Common Stock
9,840
$0.00
1
$1.33B
2022-01-31
2022-02-02
ROTE WILLIAM
Senior Vice President, R&D
A - Grant
Employee stock option (right to buy)
39,360
$0.00
1
$1.33B
2022-01-31
2022-02-02
ROTE WILLIAM
Senior Vice President, R&D
A - Grant
Performance-based restricted stock units
17,840
$0.00
2
$1.33B
2022-01-31
2022-02-02
CALVIN SANDRA
VP, Corp Controller and CAO
A - Grant
Common Stock
8,750
$0.00
1
$1.33B
2022-01-31
2022-02-02
ROTE WILLIAM
Senior Vice President, R&D
A - Grant
Common Stock
9,840
$0.00
1
$1.33B
2022-01-31
2022-02-02
CALVIN SANDRA
VP, Corp Controller and CAO
S - Sale
Common Stock
-798
$27.00
-21,546
1
$1.33B
2022-01-31
2022-02-02
CLAGUE LAURA
Chief Financial Officer
S - Sale
Common Stock
-1,238
$27.00
-33,426
1
$1.33B
2022-01-24
2022-01-26
CLAGUE LAURA
Chief Financial Officer
S - Sale
Common Stock
-2,063
$25.00
-51,575
1
$1.33B
2022-01-24
2022-01-26
CALVIN SANDRA
VP, Corp Controller and CAO
S - Sale
Common Stock
-934
$25.00
-23,350
1
$1.33B
2022-01-24
2022-01-26
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-7,873
$25.00
-197K
1
$1.33B
2022-01-24
2022-01-26
HEERMA PETER
Chief Commercial Officer
S - Sale
Common Stock
-1,875
$25.00
-46,875
1
$1.33B
2022-01-24
2022-01-26
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-2,250
$25.00
-56,250
1
$1.33B
2022-01-24
2022-01-26
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-1,875
$25.00
-46,875
1
$1.33B
2022-01-11
2022-01-12
CLAGUE LAURA
Chief Financial Officer
S - Sale
Common Stock
-7,500
$27.00
-203K
1
$1.33B
2022-01-11
2022-01-12
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-5,000
$27.00
-135K
1
$1.33B
2022-01-11
2022-01-12
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-2,500
$27.00
-67,500
1
$1.33B
2022-01-10
2022-01-12
ROTE WILLIAM
Senior Vice President, R&D
A - Grant
Common Stock
5,000
$0.00
1
$1.33B
2022-01-10
2022-01-12
CLAGUE LAURA
Chief Financial Officer
A - Grant
Common Stock
7,500
$0.00
1
$1.33B
2022-01-10
2022-01-12
REED ELIZABETH
SVP, GC & Corporate Secretary
A - Grant
Common Stock
5,000
$0.00
1
$1.33B
2022-01-05
2022-01-06
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-12,500
$30.00
-375K
2
$1.33B
2022-01-04
2022-01-06
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-4,832
$30.00
-145K
1
$1.33B
2022-01-01
2022-01-04
INRIG JULA
Chief Medical Officer
A - Grant
Common Stock
20,000
$0.00
1
$1.33B
2022-01-01
2022-01-04
INRIG JULA
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
80,000
$0.00
1
$1.33B
2021-11-16
2021-11-18
ASELAGE STEVE
S - Sale
Common Stock
-31,800
$29.00
-922K
1
$1.33B
2021-11-05
2021-11-09
ASELAGE STEVE
S - Sale
Common Stock
-10,000
$26.00
-260K
1
$1.33B
2021-11-05
2021-11-09
ASELAGE STEVE
M - Exercise
Common Stock
10,000
$16.00
160K
1
$1.33B
2021-11-05
2021-11-09
ASELAGE STEVE
M - Exercise
Employee stock option (right to buy)
-10,000
$0.00
1
$1.33B
2021-11-02
2021-11-03
ASELAGE STEVE
S - Sale
Common Stock
-3,500
$30.00
-105K
1
$1.33B
2021-11-01
2021-11-03
ASELAGE STEVE
S - Sale
Common Stock
-5,000
$29.00
-145K
1
$1.33B
2021-07-16
2021-11-03
ASELAGE STEVE
G - Gift
Common Stock
3,000
$0.00
1
$1.33B
2021-07-16
2021-11-03
ASELAGE STEVE
G - Gift
Common Stock
-3,000
$0.00
1
$1.33B
2021-02-04
2021-11-03
ASELAGE STEVE
G - Gift
Common Stock
-25,000
$0.00
1
$1.33B
2021-02-04
2021-11-03
ASELAGE STEVE
G - Gift
Common Stock
25,000
$0.00
1
$1.33B
2021-10-07
2021-10-08
ASELAGE STEVE
M - Exercise
Employee stock option (right to buy)
-60,000
$0.00
1
$1.33B
2021-10-07
2021-10-08
ASELAGE STEVE
S - Sale
Common Stock
-60,000
$26.00
-1.56M
2
$1.33B
2021-10-07
2021-10-08
ASELAGE STEVE
M - Exercise
Common Stock
60,000
$16.00
960K
1
$1.33B
2021-10-04
2021-10-05
HEERMA PETER
Chief Commercial Officer
S - Sale
Common Stock
-3,058
$25.00
-76,450
1
$1.33B
2021-09-14
2021-09-16
BRINKLEY RUTH WILLIAMS
A - Grant
Common Stock
5,250
$0.00
1
$1.33B
2021-09-14
2021-09-16
BRINKLEY RUTH WILLIAMS
A - Grant
Stock Option (Right to Buy)
15,750
$0.00
1
$1.33B
2021-08-17
2021-08-17
ROSENBERG NOAH
Chief Medical Officer
S - Sale
Common Stock
-1,407
$17.00
-23,919
1
$1.33B
2021-08-17
2021-08-17
CLAGUE LAURA
Chief Financial Officer
S - Sale
Common Stock
-1,407
$17.00
-23,919
1
$1.33B
2021-08-17
2021-08-17
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-7,836
$17.00
-133K
1
$1.33B
2021-08-17
2021-08-17
HEERMA PETER
Chief Commercial Officer
S - Sale
Common Stock
-1,407
$17.00
-23,919
1
$1.33B
2021-08-17
2021-08-17
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-1,407
$17.00
-23,919
1
$1.33B
2021-08-17
2021-08-17
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-1,407
$17.00
-23,919
1
$1.33B
2021-08-13
2021-08-17
CLAGUE LAURA
Chief Financial Officer
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2021-08-13
2021-08-17
DUBE ERIC
Chief Executive Officer
A - Grant
Common Stock
17,500
$0.00
1
$1.33B
2021-08-13
2021-08-17
HEERMA PETER
Chief Commercial Officer
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2021-08-13
2021-08-17
ROSENBERG NOAH
Chief Medical Officer
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2021-08-13
2021-08-17
REED ELIZABETH
SVP, GC & Corporate Secretary
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2021-08-13
2021-08-17
ROTE WILLIAM
Senior Vice President, R&D
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2021-07-28
2021-07-29
ROSENBERG NOAH
Chief Medical Officer
S - Sale
Common Stock
-1,250
$14.00
-17,500
1
$1.33B
2021-06-02
2021-06-03
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-4,780
$14.00
-66,920
1
$1.33B
2021-06-01
2021-06-03
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-4,782
$15.00
-71,730
1
$1.33B
2021-05-14
2021-05-18
SQUARER RON
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
BRUHN SUZANNE LOUISE
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
BRUHN SUZANNE LOUISE
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
COUGHLIN TIMOTHY
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
COUGHLIN TIMOTHY
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
LYONS GARY
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
ASELAGE STEVE
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
ASELAGE STEVE
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
BAYNES ROY
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
BAYNES ROY
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
LYONS GARY
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
MECKLER JEFFREY
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
MECKLER JEFFREY
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
ORWIN JOHN
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
ORWIN JOHN
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
POOLE SANDRA
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
POOLE SANDRA
A - Grant
Common Stock
3,000
$0.00
1
$1.33B
2021-05-14
2021-05-18
SQUARER RON
A - Grant
Stock option (right to buy)
9,000
$0.00
1
$1.33B
2021-05-12
2021-05-13
CLAGUE LAURA
Chief Financial Officer
S - Sale
Common Stock
-2,000
$19.00
-38,000
1
$1.33B
2021-05-12
2021-05-13
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-1,625
$19.00
-30,875
1
$1.33B
2021-05-12
2021-05-13
ROSENBERG NOAH
Chief Medical Officer
S - Sale
Common Stock
-375
$19.00
-7,125
1
$1.33B
2021-05-12
2021-05-13
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-1,562
$19.00
-29,678
1
$1.33B
2021-05-11
2021-05-13
CLAGUE LAURA
Chief Financial Officer
S - Sale
Common Stock
-2,000
$19.00
-38,000
1
$1.33B
2021-05-11
2021-05-13
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-1,563
$19.00
-29,697
1
$1.33B
2021-05-11
2021-05-13
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-1,625
$19.00
-30,875
1
$1.33B
2021-05-11
2021-05-13
ASELAGE STEVE
S - Sale
Common Stock
-2,146
$20.00
-42,920
1
$1.33B
2021-05-11
2021-05-13
ROSENBERG NOAH
Chief Medical Officer
S - Sale
Common Stock
-375
$19.00
-7,125
1
$1.33B
2021-04-16
2021-04-20
ASELAGE STEVE
S - Sale
Common Stock
-10,000
$26.00
-260K
1
$1.33B
2021-04-16
2021-04-20
ASELAGE STEVE
M - Exercise
Employee stock option (right to buy)
-10,000
$0.00
1
$1.33B
2021-04-16
2021-04-20
ASELAGE STEVE
M - Exercise
Common Stock
10,000
$16.00
160K
1
$1.33B
2021-03-17
2021-03-19
ASELAGE STEVE
S - Sale
Common Stock
-17,727
$27.00
-479K
2
$1.33B
2021-03-17
2021-03-19
ASELAGE STEVE
M - Exercise
Common Stock
10,000
$16.00
160K
1
$1.33B
2021-03-17
2021-03-19
ASELAGE STEVE
M - Exercise
Employee stock option (right to buy)
-10,000
$0.00
1
$1.33B
2021-02-18
2021-02-18
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-1,250
$29.00
-36,250
1
$1.33B
2021-02-17
2021-02-18
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-1,250
$27.00
-33,750
1
$1.33B
2021-02-08
2021-02-09
HEERMA PETER
Chief Commercial Officer
S - Sale
Common Stock
-1,125
$32.00
-36,000
1
$1.33B
2021-02-08
2021-02-09
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-4,813
$32.00
-154K
1
$1.33B
2021-02-08
2021-02-09
CLAGUE LAURA
Chief Financial Officer
S - Sale
Common Stock
-2,250
$32.00
-72,000
1
$1.33B
2021-02-08
2021-02-09
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-2,250
$32.00
-72,000
1
$1.33B
2021-02-08
2021-02-09
ROSENBERG NOAH
Chief Medical Officer
S - Sale
Common Stock
-1,125
$32.00
-36,000
1
$1.33B
2021-02-08
2021-02-09
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-2,250
$32.00
-72,000
1
$1.33B
2021-02-05
2021-02-09
CLAGUE LAURA
Chief Financial Officer
S - Sale
Common Stock
-2,250
$31.00
-69,750
1
$1.33B
2021-02-05
2021-02-09
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-4,813
$31.00
-149K
1
$1.33B
2021-02-05
2021-02-09
HEERMA PETER
Chief Commercial Officer
S - Sale
Common Stock
-1,125
$31.00
-34,875
1
$1.33B
2021-02-05
2021-02-09
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-2,250
$31.00
-69,750
1
$1.33B
2021-02-05
2021-02-09
ROSENBERG NOAH
Chief Medical Officer
S - Sale
Common Stock
-1,125
$31.00
-34,875
1
$1.33B
2021-02-05
2021-02-09
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-2,250
$31.00
-69,750
1
$1.33B
2021-02-03
2021-02-05
REED ELIZABETH
SVP, GC & Corporate Secretary
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2021-02-03
2021-02-05
ROSENBERG NOAH
Chief Medical Officer
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2021-02-03
2021-02-05
CLAGUE LAURA
Chief Financial Officer
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2021-02-03
2021-02-05
ROTE WILLIAM
Senior Vice President, R&D
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2021-02-03
2021-02-05
DUBE ERIC
Chief Executive Officer
A - Grant
Common Stock
17,500
$0.00
1
$1.33B
2021-02-03
2021-02-05
HEERMA PETER
Chief Commercial Officer
A - Grant
Common Stock
4,500
$0.00
1
$1.33B
2021-02-03
2021-02-03
CLAGUE LAURA
Chief Financial Officer
S - Sale
Common Stock
-3,625
$29.00
-105K
2
$1.33B
2021-02-03
2021-02-03
HEERMA PETER
Chief Commercial Officer
S - Sale
Common Stock
-563
$29.00
-16,327
1
$1.33B
2021-02-03
2021-02-03
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-3,175
$29.00
-92,075
2
$1.33B
2021-02-03
2021-02-03
ROSENBERG NOAH
Chief Medical Officer
S - Sale
Common Stock
-1,813
$29.00
-52,577
2
$1.33B
2021-02-03
2021-02-03
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-3,625
$29.00
-105K
2
$1.33B
2021-02-03
2021-02-03
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-2,406
$29.00
-69,774
1
$1.33B
2021-02-02
2021-02-03
HEERMA PETER
Chief Commercial Officer
S - Sale
Common Stock
-563
$31.00
-17,453
1
$1.33B
2021-02-21
2021-02-02
ASELAGE STEVE
M - Exercise
Employee stock option (right to buy)
-25,000
$0.00
1
$1.33B
2021-02-02
2021-02-02
ROTE WILLIAM
Senior Vice President, R&D
S - Sale
Common Stock
-3,625
$31.00
-112K
2
$1.33B
2021-02-02
2021-02-02
ASELAGE STEVE
S - Sale
Common Stock
-25,000
$31.00
-775K
1
$1.33B
2021-02-02
2021-02-02
CLAGUE LAURA
Chief Financial Officer
S - Sale
Common Stock
-3,625
$31.00
-112K
2
$1.33B
2021-02-02
2021-02-02
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-8,734
$30.00
-262K
2
$1.33B
2021-02-02
2021-02-02
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-3,175
$31.00
-98,425
2
$1.33B
2021-02-02
2021-02-02
ROSENBERG NOAH
Chief Medical Officer
S - Sale
Common Stock
-1,813
$31.00
-56,203
2
$1.33B
2021-02-02
2021-02-02
ASELAGE STEVE
M - Exercise
Common Stock
25,000
$10.00
250K
1
$1.33B
2021-01-31
2021-02-02
ROTE WILLIAM
Senior Vice President, R&D
A - Grant
Common Stock
5,000
$0.00
1
$1.33B
2021-01-31
2021-02-02
CLAGUE LAURA
Chief Financial Officer
A - Grant
Common Stock
5,000
$0.00
1
$1.33B
2021-01-31
2021-02-02
DUBE ERIC
Chief Executive Officer
A - Grant
Common Stock
15,000
$0.00
1
$1.33B
2021-01-31
2021-02-02
REED ELIZABETH
SVP, GC & Corporate Secretary
A - Grant
Common Stock
5,000
$0.00
1
$1.33B
2021-01-31
2021-02-02
ROSENBERG NOAH
Chief Medical Officer
A - Grant
Common Stock
5,000
$0.00
1
$1.33B
2021-01-21
2021-01-28
DUBE ERIC
Chief Executive Officer
A - Grant
Employee stock option (right to buy)
213K
$0.00
1
$1.33B
2021-01-21
2021-01-25
CLAGUE LAURA
Chief Financial Officer
A - Grant
Employee stock option (right to buy)
57,500
$0.00
1
$1.33B
2021-01-21
2021-01-25
CLAGUE LAURA
Chief Financial Officer
A - Grant
Common Stock
15,000
$0.00
1
$1.33B
2021-01-21
2021-01-25
DUBE ERIC
Chief Executive Officer
A - Grant
Employee stock option (right to buy)
213K
$0.00
1
$1.33B
2021-01-21
2021-01-25
DUBE ERIC
Chief Executive Officer
A - Grant
Common Stock
57,260
$0.00
1
$1.33B
2021-01-21
2021-01-25
HEERMA PETER
Chief Commercial Officer
A - Grant
Employee stock option (right to buy)
57,500
$0.00
1
$1.33B
2021-01-21
2021-01-25
HEERMA PETER
Chief Commercial Officer
A - Grant
Common Stock
15,000
$0.00
1
$1.33B
2021-01-21
2021-01-25
REED ELIZABETH
SVP, GC & Corporate Secretary
A - Grant
Employee stock option (right to buy)
57,500
$0.00
1
$1.33B
2021-01-21
2021-01-25
REED ELIZABETH
SVP, GC & Corporate Secretary
A - Grant
Common Stock
15,000
$0.00
1
$1.33B
2021-01-21
2021-01-25
ROSENBERG NOAH
Chief Medical Officer
A - Grant
Employee stock option (right to buy)
57,500
$0.00
1
$1.33B
2021-01-21
2021-01-25
ROTE WILLIAM
Senior Vice President, R&D
A - Grant
Employee stock option (right to buy)
57,500
$0.00
1
$1.33B
2021-01-21
2021-01-25
ROTE WILLIAM
Senior Vice President, R&D
A - Grant
Common Stock
15,000
$0.00
1
$1.33B
2021-01-21
2021-01-25
ROSENBERG NOAH
Chief Medical Officer
A - Grant
Common Stock
15,000
$0.00
1
$1.33B
2021-01-06
2021-01-07
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-688
$27.00
-18,576
1
$1.33B
2021-01-06
2021-01-07
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-3,438
$27.00
-92,826
1
$1.33B
2021-01-05
2021-01-07
DUBE ERIC
Chief Executive Officer
S - Sale
Common Stock
-3,438
$27.00
-92,826
1
$1.33B
2021-01-05
2021-01-07
REED ELIZABETH
SVP, GC & Corporate Secretary
S - Sale
Common Stock
-688
$27.00
-18,576
1
$1.33B
2020-12-15
2020-12-16
ASELAGE STEVE
S - Sale
Common Stock
-5,549
$26.00
-144K
1
$1.33B
2020-12-02
2020-12-04
ASELAGE STEVE
S - Sale
Common Stock
-7,891
$23.00
-181K
1
$1.33B
2020-11-19
2020-12-04
ASELAGE STEVE
G - Gift
Common Stock
-3,000
$0.00
1
$1.33B